27 May 2021	IP Group plc Portfolio company Pulmocide completes $92m (£65m*) Series C financing round
17 May 2021	IP Group plc Additional fair value gain of £20m
05 May 2021	IP Group plc Portfolio company Kuur Therapeutics Ltd acquired by Nasdaq-listed Athenex Inc for up to $185m (£133m*)
05 May 2021	IP Group plc Portfolio company Inivata acquired by Nasdaq-listed NeoGenomics
04 May 2021	IP Group plc Portfolio company Oxford Nanopore Technologies raises £195m in new investment
30 Mar 2021	IP Group plc Portfolio company Oxford Nanopore Technologies announces preparation for IPO in the second half of 2021
26 Mar 2021	IP Group plc Portfolio company Diurnal announces European Medicine Agency issues positive opinion for Chronocort® in Europe
10 Mar 2021	IP Group plc Annual Results
08 Mar 2021	Blog the women who inspire us
17 Feb 2021	IP Group plc Portfolio company ApcinteX acquired by Centessa Pharmaceuticals